Fountain Healthcare Partners
Venture capitalDublin · Seed–Series B · 8 people tracked
Find your way into Fountain Healthcare Partners
402 people in our graph share verified history with the Fountain Healthcare Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Fountain Healthcare Partners invests risk capital in ambitious founders building life sciences companies across specialty pharma, biopharmaceuticals, medical devices, and diagnostics. Drawing on over 30 years of investment experience, the firm follows a focused strategy aimed at creating value for both investors and portfolio companies. It targets seed and early-stage opportunities in Europe and the United States, seeking companies with the potential for a significant exit within three to six years of initial investment. The firm typically leads or co-leads investment syndicates and is committed to responsible investing.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directories
What they invest in
from 16 of 31 portfolio companiesHealthtech ×13Medical Devices ×9Biotech ×8Digital Health ×3AI & Machine Learning ×2Hardware ×2Longevity ×2EdTech ×1
HQs:United States×8Germany×1Ireland×1
Investments · 31 tracked
founders shown can be your intro pathBy year:2024 · 22023 · 12016 · 12014 · 15 dated
Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity.
BiotechDigital HealthHealthtechLongevity
Philip JaniakinMarie-Laure OzouxinRégis OlivierinFrancesca C. LawsonMark KowalaEleonore Jouannyin
Co-investorsJeito CapitalKurma PartnersOrbiMedV-Bio VenturesOmnes CapitalInvivo Capital Partners+1 more
Priothera is a clinical-stage biotech developing mocravimod (an S1P receptor modulator) for hematologic malignancies such as acute myeloid leukemia.
BiotechHealthtech
Florent Gros(Chief Executive Officer and Founder)Stephan Oehen(Chief Operating Officer and Founder)inBrice Suire(Chief Financial Officer and Founder)Nigel Clark(Chief Business Officer)Jens Hasskarl(Chief Medical Officer)
Co-investorsHealthCap4see Ventures
XyloCor Therapeutics develops gene therapies for advanced coronary artery disease and cardiac damage.
BiotechHealthtechMedical DevicesMalvern, US
Ronald Crystal(Co-founder)Todd Rosengart(Co-founder)John Tucker(President and Chief Executive Officer)Albert Gianchetti(Executive Officer, Director)
BoardGlenn Batchelder(Director)inJames Cohen(Director)
Co-investorsLumira VenturesJeito CapitalLongwood FundSofinnova Ventures
Amarin Corporation is a cardiovascular health pharmaceutical company developing treatments to prevent cardiovascular disease.
BiotechHealthtechMedical Devices
Co-investorsAvoro Capital AdvisorsLongitude CapitalSignet Healthcare PartnersSofinnova Ventures
Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.
AI & Machine LearningEnterprise SoftwareSaaS
Co-investorsPebblebedAndera PartnersBGVForbionHTGFPMV+2 more
HealthtechHayward, US
GUY DIPIERRO(Director)inALAN LEVY, PH.D.(Executive Officer, Director)ANTHONY RIMAC(Executive Officer)ALAN LEVY(Executive Officer, Director)
BoardELIZABETH ROCKETT(Director)WENDE HUTTON(Director)in
Co-investorsEmergent Medical Partners, LLPKaiser Permanente VenturesMission Bay Capital5AM VenturesCanaan PartnersGE Ventures
Exciva is a company focused on neurological and neurodegenerative conditions, led by a team with expertise in chemistry, clinical operations, and regulatory affairs.
BiotechDigital HealthLongevityMedical DevicesHeidelberg, DE
Hans Moebius(Co-founder and CMO, Head of Clinical Operations)inAnton Bespalov(Co-founder and CSO, Head of Regulatory Affairs)in
Co-investorsAndera PartnersLifeArc VenturesModi Ventures
AdmitHub provides AI-powered success coaching and conversation tools for higher education institutions to improve student engagement, retention, and outcomes.
AI & Machine LearningEdTechHR TechArlington, US
Andrew Magliozzi(Founder)in
Co-investorsFundersClubMichelson 20MM FoundationNXT VenturesTechstarsAlly Bridge GroupGilde Healthcare+3 more
HealthtechPlymouth, US
Dan Sachs(Director)Peter Crosby(Executive Officer, Director)inJason Hannonin
BoardManus Rogan(Director)inAntoine Papiernik(Director)in
Co-investorsSofinnova PartnersAlly Bridge GroupGilde HealthcareViking Global Investors
MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.
HealthtechMedical DevicesRoboticsJacksonville, US
Mark Toland(Executive Officer, Director)inAndrew Cleeland(Director)Justin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)
Co-investorsAndera PartnersBioStar CapitalDeerfield Management CompanyFidelity InvestmentsRA CapitalCorewell Health Ventures
Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients.
HealthtechMedical Devices
Co-investorsAtlantic Bridge VenturesClaret Capital PartnersEnterprise IrelandEQT Life SciencesSofinnova PartnersWestern Development Commission
Neurent Medical develops a minimally invasive radiofrequency ablation system to treat chronic rhinitis by disrupting hyperactive autonomic nerves in the nasal passages.
HardwareHealthtechMedical Devices
Co-investorsAtlantic Bridge Ventures
Neuromod is a medical technology company that developed Lenire, an FDA-approved bimodal neuromodulation device for treating tinnitus.
HardwareHealthtechMedical Devices
Ross O'Neill(Founder)in
Co-investorsXB Ventures
Spark Therapeutics, now part of the Roche Group, focuses on delivering therapies to improve patient outcomes and create healthier communities.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsSofinnova Ventures
AbbVie is a pharmaceutical company that discovers and develops medicines, working with external innovation partners to conduct research.
BiotechHealthtech
Co-investorsArtis VenturesNew Enterprise Associates (NEA)Fidelity InvestmentsFounders Fund
Vivasure Medical develops polymer-based vascular closure devices and delivery systems for structural heart and endovascular interventions.
BiotechHealthtechMedical DevicesGalway, IE
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AcordaAda Health Partners with BayerArravascCalypso BiotechCappella MedDualyxErmiumInflazomeInnocollMitsuiventuresNerre TherapeuticsOpsonaPalyonmedicalTrinotherapeuticsVelicept
Portfolio news
latest coverage across their companiesMainstay · vctavern.com · May 13, 2026
Neurent Medical · mondaq.com · Feb 26, 2026
Mainstay Medical · mainstaymedical.com · Oct 1, 2025
Frequently asked questions
- How many investments has Fountain Healthcare Partners made?
- Fountain Healthcare Partners has 31 tracked investments.
- What stage does Fountain Healthcare Partners invest at?
- Fountain Healthcare Partners invests at the Seed, Series A, Series B stages.
- What is Fountain Healthcare Partners's typical check size?
- Fountain Healthcare Partners typically writes checks of $10.8M – $16.2M.
- What sectors does Fountain Healthcare Partners focus on?
- Fountain Healthcare Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Fountain Healthcare Partners located?
- Fountain Healthcare Partners is headquartered in Dublin, IE.
- Does Fountain Healthcare Partners lead rounds?
- Yes, Fountain Healthcare Partners leads investment rounds.
- Who does Fountain Healthcare Partners co-invest with?
- Fountain Healthcare Partners most often shares deals with Andera Partners, Sofinnova Ventures, LifeArc Ventures, among 26 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.